Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.

Lazaros LazaridisNiklas SchäferSarah Teuber-HanselmannTobias BlauTeresa SchmidtChristoph OsterJohannes WellerTheophilos TzaridisDaniela PierscianekKathy KeyvaniChristoph KleinschnitzMartin StuschkeBjörn SchefflerCornelius DeuschlUlrich SureUlrich HerrlingerSied KebirMartin Glas

Published in: Journal of cancer research and clinical oncology (2019)

This analysis provides first indication that the combination of TTFields/lomustine/temozolomide is safe and feasible. The observed survival outcomes might suggest potential beneficial effects.

Keyphrases

newly diagnosed
risk assessment
climate change